636. Meningococcal Vaccination and Antibiotic Prophylaxis Practices in Solid Organ Transplant Recipients undergoing Eculizumab Therapy

BACKGROUND: Eculizumab, an inhibitor of terminal complement activation, has been utilized in pre-transplant desensitization, treatment of antibody-mediated rejection and thrombotic microangiopathy in solid organ transplant recipients (SOTR). Eculizumab is associated with meningococcal disease, leadi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhaimia, Eric, Yetmar, Zachary A, Mahmood, Maryam, Stacy, Bernard, Stephen, Jenise, Vikram, Holenarasipur R, Brumble, Lisa M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752852/
http://dx.doi.org/10.1093/ofid/ofac492.688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752852/
http://dx.doi.org/10.1093/ofid/ofac492.688

Ejemplares similares